FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to chemical-pharmaceutical industry and represents a pharmaceutical composition containing transnorsertraline or its pharmaceutically acceptable salt or solvate, and mannitol or xylitol, as well as to a method of treating, preventing or reducing recurrent neurological disturbance, involving administration of the above composition into the patient.
EFFECT: invention provides creating the pharmaceutical composition of transnorsertraline, possessing improved chemical and physical stability.
11 cl, 26 tbl, 10 dwg
| Title |
Year |
Author |
Number |
| THERAPEUTIC COMBINATION OF AMLODIPINE AND BENAZEPRIL/BENAZEPRILATE |
2001 |
- Komfort Ann Ris
- Dejlej Uill'Jam Lajonel
- Fleres Santo Dzhozef
- Rojs Alan Ehduard
- Uehbb Randi Li
- Uej Uill'Jam Shajfeng
|
RU2292206C2 |
| PHARMACEUTICAL COMBINATION, COMPOSITION, AND COMBINED COMPOSITION, CONTAINING GLUCOKINASE ACTIVATOR AND PPAR RECEPTOR ACTIVATOR, AND THEIR PREPARATION METHOD, AND THEIR USE |
2019 |
- Chen, Li
- Li, Yongguo
- Wang, Gaosen
- Gao, Huisheng
|
RU2781638C2 |
| CRYSTALLINE FORMS OF FINGOLIMOD HYDROCHLORIDE |
2009 |
- Mikhaehl' Mutts
- Guido Jordine
|
RU2549899C2 |
| PHARMACEUTICAL COMPOSITIONS COMPRISING 5,8,14-TRIAZATETRACYCLO[10,3,1,0(2,11),0(4,9)HEXADECA-2( 11),3,5,7,9-PENTAENE |
2002 |
- Am Ehnde Mehri Tanja
- Roj Majkl Kristofer
- Smit Skott Uehndell
- Uoterman Kennet Krehjg
- Mouzes Sara Kristen
- Kvan Ehrnest Shing
|
RU2272629C2 |
| COMBINATION OF MIRTAZAPINE AND TIZANIDINE FOR USE IN PAIN DISORDERS |
2019 |
- Beniashvili Allan Gerovich
- Morozova Margarita Alekseevna
- Zapolskij Maksim Eduardovich
|
RU2736713C1 |
| GLUCOSAMINE PROLONGED RELEASE DOSAGE FORM |
2011 |
- Bothra Pukhraj Chandanmal
- Nsv Raju
- Kandarapu Raghupathi
- Sambasiva Rao Maram
- T Mahesh Kumar
- Srinivasan R
|
RU2521231C2 |
| PHARMACEUTICAL COMPOSITIONS CONTAINING S1P RECEPTOR MODULATOR |
2007 |
- Ambjul' Mikhaehl'
- Bejer Jutta
- Karreno-Gomes Begona
- R'Jugger Kollin
- Valazza Stiven
|
RU2487703C2 |
| PHARMACEUTICAL COMBINATION, COMPOSITION, AND COMBINED COMPOSITION CONTAINING GLUCOKINASE ACTIVATOR AND BIGUANIDE HYPOGLYCEMIC DRUG, AS WELL AS THEIR PREPARATION METHOD, AND THEIR USE |
2019 |
- Chen, Li
- Li, Yongguo
- Wang, Gaosen
|
RU2780377C2 |
| R(-)-N-[4,4-DI-(3-METHYLTHIENE-2-YL)-BUT-3-ENYL]-NIPECOTIC ACID HYDROCHLORIDE ANHYDROUS CRYSTALLINE FORM, METHOD OF ITS PREPARING, PHARMACEUTICAL COMPOSITION AND METHOD OF TREATMENT |
1997 |
- Arntt Preben
- Petersen Khenning Berge
- Chang Vinsent Kh.
- Allen Kimberli Ehnn
- Chejn Majkl Kh.
|
RU2177478C2 |
| COMBINED CONTROLLED-RELEASE PHARMACEUTICAL AGENT CONTAINING DIHYDROPYRIDINE CALCIUM CANAL BLOCKERS AND HMG-CoA-REDUCTASE INHIBITORS |
2007 |
- Kim Sung Vuk
- Dzun Sung Soo
- Dzo Joung Gvan
- Koo Dza-Seong
- Kim Dzin Vook
|
RU2450804C2 |
